Risk-based Regulation Proposed for DTC Genetic Tests | GenomeWeb

By Matt Jones

NEW YORK (GenomeWeb News) – Since premarket studies are not likely to fully answer questions about the safety and effectiveness of genetic tests, those that are sold directly to consumers should be regulated through a system that incorporates risk-stratification and post-market surveillance, according to a new policy opinion proposal published today in Science.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: statistical approach to examine intra-tumor heterogeneity, new genetic condition called otulipenia, and more.

Blood tests looking for biomarker changes could catch mental illnesses earlier, Newsweek reports.

DNA testing offers Korean adoptees a way to find their birth parents that sidesteps bureaucratic red tape, according to the New York Times.

A National Institutes of Health researcher has filed an Equal Employment Opportunity complaint against the agency, the Washington Post reports.